Peripheral Neuropathy Trial, Recruiting NCT06869928 Sponsor: University of British Columbia Condition: Peripheral Neuropathy
Back to Peripheral Neuropathy

Peripheral Neuropathy Trial, Recruiting

NCT06869928
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Children between 6 months and 18 years old who have a severe neurological impairment (from any cause) and are experiencing pain and irritability that cannot be explained
  • Children whose thinking or communication difficulties make it impossible to determine where their pain is, what is causing it, or what type of pain it is
  • Children who have cognitive (thinking and learning) impairment or who are non-verbal (unable to speak)
  • Parents or guardians who have enough English skills, or have someone to help them, to attend clinic visits and complete surveys
  • General pediatricians (children's doctors) who practice at a community clinic in British Columbia

Who may not be able to join:

  • Children who are outside the age range of 6 months to 18 years old
  • Children who are able to communicate and have enough cognitive development to point to or describe where their pain is
  • Children whose pain and irritability already has a known and treatable cause
  • Parents or guardians who do not have sufficient English skills and do not have access to someone who can assist them with clinic visits and surveys
  • Healthcare professionals who are not general pediatricians, such as specialist pediatricians, nurse practitioners, nurses, or other allied health professionals

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Hal Siden, MD, University of British Columbia and BC Children's Hospital Research Institute

Phone: 604-875-2345

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
28 June 2024
Est. completion
1 March 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Implementation Adoption; Implementation Reach; Implementation Acceptability; PIUO Pain Pathway Effectiveness

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov